Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Sun Pharma shares continue to fall following USFDA observations at Halol Plant

      Sun Pharma shares continue to fall following USFDA observations at Halol Plant

      Medical Dialogues Bureau11 Sept 2018 11:52 AM IST
      New Delhi: Shares of Sun Pharmaceutical Industries fell for the second straight session Monday, dropping almost 4 per cent after USFDA issued Form 483...
      Mercks Blockbuster Drug Keytruda win EU approval for combination use in Lung Cancer

      Merck's Blockbuster Drug Keytruda win EU approval for combination use in Lung Cancer

      Medical Dialogues Bureau11 Sept 2018 11:48 AM IST
      The Keytruda/chemo combination is already approved in the United States. But last October the U.S. drugmaker withdrew an application for European...
      Alembic Pharma okays proposal to raise up to Rs 300 cr via NCDs, informs BSE

      Alembic Pharma okays proposal to raise up to Rs 300 cr via NCDs, informs BSE

      Medical Dialogues Bureau11 Sept 2018 11:42 AM IST
      The company, however, did not mention what it intended to do with the funds it is looking to raise.New Delhi: Alembic Pharmaceuticals said its board...
      U.S. appeals court invalidates Acorda patents on MS drug

      U.S. appeals court invalidates Acorda patents on MS drug

      Medical Dialogues Bureau11 Sept 2018 9:00 AM IST
      A U.S. appeals court on invalidated Acorda Therapeutics Inc patents covering its multiple sclerosis drug Ampyra, opening the door for generic...
      Glenmark Pharma arm gets approval for generic asthma drug in Germany

      Glenmark Pharma arm gets approval for generic asthma drug in Germany

      Medical Dialogues Bureau10 Sept 2018 10:30 AM IST
      New Delhi: Glenmark Pharma's subsidiary has secured marketing authorization in Germany for the generic version of GlaxoSmithKline's Seretide...
      Roche faces UK pricing row over multiple sclerosis drug Ocrevus

      Roche faces UK pricing row over multiple sclerosis drug Ocrevus

      Medical Dialogues Bureau10 Sept 2018 10:00 AM IST
      LONDON: Roche faces a fresh row over drug pricing in Britain, following a decision by the body responsible for medicine use within the state health...
      US redirecting 25 million dollar in aid for East Jerusalem hospitals

      US redirecting 25 million dollar in aid for East Jerusalem hospitals

      Medical Dialogues Bureau10 Sept 2018 9:45 AM IST
      Washington: The Trump administration said that it is cutting USD 25 million meant for East Jerusalem hospitals and putting the money toward...
      Maryland charges Insys with engaging in deceptive opioid scheme

      Maryland charges Insys with engaging in deceptive opioid scheme

      Medical Dialogues Bureau10 Sept 2018 9:30 AM IST
      Maryland charged Insys Therapeutics Inc with deceptively marketing a powerful opioid painkiller so that it was prescribed inappropriately beyond its...
      USFDA completes inspection at Caplin Point Labs sterile injectable facility in Tamil Nadu

      USFDA completes inspection at Caplin Point Lab's sterile injectable facility in Tamil Nadu

      Medical Dialogues Bureau9 Sept 2018 10:45 AM IST
      New Delhi: Caplin Point Laboratories said the US health regulator has completed the inspection at its sterile injectable facility in Gummudipoondi in...
      GSK says USFDA wants more information on pulmonary drug

      GSK says USFDA wants more information on pulmonary drug

      Medical Dialogues Bureau8 Sept 2018 9:45 AM IST
      LONDON: GlaxoSmithKline (GSK) said that U.S. health authorities had asked for more information about its Nucala drug for use in combating chronic...
      French drugmakers urge Brexit negotiators to safeguard supply chain

      French drugmakers urge Brexit negotiators to safeguard supply chain

      Medical Dialogues Bureau8 Sept 2018 9:30 AM IST
      French drugmakers are urging European and British negotiators ahead of a crunch Brexit meeting next month to ensure the free circulation of medicines...
      Lupin to train over 1,000 graduates for pharma industry

      Lupin to train over 1,000 graduates for pharma industry

      Medical Dialogues Bureau7 Sept 2018 10:15 AM IST
      New Delhi: Pharmaceutical giant, Lupin Limited expects to train more than 1,000 undergraduates into pharma professionals by the year 2020 under its...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok